Hims & Hers soars on cheaper compounded versions of Novo Nordisk's semaglutide #HIMS #NVO #LLY [lixWPNUey]
Hims & Hers Health (HIMS) surged over 27% on Monday after announcing it would offer customers access to compounded versions of Novo Nordisk's (NVO) semaglutide, the active ingredient in its weight loss drug Wegovy, at a fraction of the brand-name cost. The company announced that plans for injections of its compounded semaglutide, also sold as the type 2 diabetes medication Ozempic, start at $199 per month. Hims & Hers is also offering a $79 per month plan for an oral version of semaglutide, also sold as Novo's diabetes pill Rybelsus. The list price of Wegovy is ~$1349 per month. Ozempic is ~$936 per month.
Related Videos :
- Specialist weight management service North Tyneside [9fT5cd880]
- This is Nayli’s 40lb weight loss journey (so far) [wNzEGE9QV]
- 30-Day Hibiscus Tea Challenge: 30 lbs Weight Loss [zYJd9IFxy]
- The Center for Medical Weight Loss New Patient Experience [v8wrdiBNN]
- BRENZAVVY - Your cost effective solution for managing Type 2 Diabetes [TsyfiAqsW]
Aired: December 3rd 2024
Buy Now:
Problems Playing Video? | Closed Captioning